Extend Market Exclusivity

  • Check with publisher
  • Published date: May 23, 2019
    • Shirley, New York, United States

Generally, in order to protect branded drugs from low-cost generics, the market for exclusive use of innovative drugs granted by the FDA is 12 to 16 years. Although the market exclusivity can significantly promote the financial benefits for pharmaceutical manufactures, the quick development of generics is undoubtedly runs counter to the revenue from branded drugs. Given that generics are always marketed for 80% or more off of the cost of the branded product, implementing another period of market exclusivity is therefore of great importance to those manufacturers of branded drug.

BOC Sciences has a team of highly experienced experts who are professional in development of various pharmaceutical products and re-formulation of the approved drugs. We can provide you with a wide range of market-specific extension strategies, such as enhance product performance and potential market protection, through our adequate resources of competent personnel and state-of-the-art techniques. Our experts will provide a detailed development protocol and communicate with you for optimizing very specific of the project.

https://www.bocsci.com/solutions/extend-market-exclusivity.htm

Result 0 votes
Alex Brown
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Enable and Impart Late Stage NCE or "Marketed Compounds"

    Enable and Impart Late Stage NCE or "Marketed Compounds"

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    Recently, generic drugs account for a growing proportion of the global small molecule drug market, and the biosimilars are supposed to gain more achievements in the biopharmaceutical field. More importantly, there are increasing amount of active gene...

  • Lifecycle Management

    Lifecycle Management

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    As unique products, pharmaceutical products are composed by three different life periods: early development period, highly competitive mid-life period and the significant late post-patent period. Pharmaceutical lifecycle management (LCM) represents t...

  • Late Stage Formulation Development

    Late Stage Formulation Development

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    The availability of high quality formulations that are designed to achieve therapeutically-relevant pharmacokinetic drug profiles has a pivotal role in determination of the safety and clinical efficacy of medicines. The pharmacists and pharmaceutical...